Last reviewed · How we verify

Magnesium Sulfate Infusion

Ondokuz Mayıs University · FDA-approved active Small molecule

Magnesium sulfate acts as a physiological calcium antagonist and NMDA receptor antagonist, reducing neuronal excitability and vascular smooth muscle contractility.

Magnesium sulfate acts as a physiological calcium antagonist and NMDA receptor antagonist, reducing neuronal excitability and vascular smooth muscle contractility. Used for Seizure prophylaxis in preeclampsia and eclampsia, Tocolytic agent for preterm labor delay, Hypomagnesemia correction.

At a glance

Generic nameMagnesium Sulfate Infusion
Also known asmagnesium sulphate intravenous, Magnesium sulphate, IV MgSO4
SponsorOndokuz Mayıs University
Drug classElectrolyte supplement / anticonvulsant / tocolytic agent
TargetNMDA receptor antagonist; calcium channel modulator
ModalitySmall molecule
Therapeutic areaObstetrics; Neurology; Critical Care
PhaseFDA-approved

Mechanism of action

Magnesium sulfate blocks calcium influx into cells and antagonizes N-methyl-D-aspartate (NMDA) receptors, leading to decreased neuromuscular transmission and vasodilation. This mechanism underlies its use in seizure prophylaxis, particularly in eclampsia and preeclampsia, and as a tocolytic agent to delay preterm labor.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results